Literature DB >> 18297239

Effect of thrombin tube on PSA determination, a clue for false negative in screening for prostate cancer.

Viroj Wiwanitkit1.   

Abstract

Prostate cancer is an important male carcinoma. Laboratory screening for tumor marker is the routine preventive strategy for control of this cancer. For screening, prostate specific antigen (PSA) has been proposed as a marker in the serum. In this article, the author assesses the effect of new blood collection tube, thrombin tube, on the analysis of the PSA by bioinformatics technique. Using GoFigure server, the molecular functions of thrombin, PSA and thrombin-PSA were predicted. A significant change of molecular function due to the interaction between thrombin and PSA can be found. Increased of coagulation due to the synergistic clot activation can be expected. If this occurs, the false negative can be expected and it can bring the underdiagnosis of early prostate cancer. Therefore, the recommendation for usage of thrombin tube for PSA test should be modified from general usage. Shortening of the period between blood collection and sample analysis than general case must be done.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297239     DOI: 10.1007/s11239-008-0200-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  12 in total

1.  The effect of digital rectal examination on serum levels of prostatic-specific antigen.

Authors:  M K Brawer; R B Schifman; F R Ahmann; M E Ahmann; K M Coulis
Journal:  Arch Pathol Lab Med       Date:  1988-11       Impact factor: 5.534

2.  Evaluation of a thrombin-containing blood-collection tube.

Authors:  S J Steindel
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

3.  Thrombin receptor expression is upregulated in prostate cancer.

Authors:  Varsha Kaushal; Manish Kohli; Richard A Dennis; Eric R Siegel; Walter W Chiles; Perkins Mukunyadzi
Journal:  Prostate       Date:  2006-02-15       Impact factor: 4.104

4.  Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

Authors:  David Ulmert; Charlotte Becker; Jan-Ake Nilsson; Timo Piironen; Thomas Björk; Jonas Hugosson; Göran Berglund; Hans Lilja
Journal:  Clin Chem       Date:  2005-12-29       Impact factor: 8.327

5.  Prostate-specific antigen density.

Authors:  M C Beduschi; J E Oesterling
Journal:  Urol Clin North Am       Date:  1997-05       Impact factor: 2.241

6.  Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.

Authors:  T K Takayama; K Fujikawa; E W Davie
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

7.  Correlates of thrombin generation in patients with advanced prostate cancer.

Authors:  Stuart E Lind; Joseph A Caprini; Sofia Goldshteyn; James C Dohnal; Sara K Vesely; Daniel H Shevrin
Journal:  Thromb Haemost       Date:  2003-01       Impact factor: 5.249

Review 8.  Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.

Authors:  Elizabeth A Platz; Angelo M De Marzo; Edward Giovannucci
Journal:  J Cell Biochem       Date:  2004-02-15       Impact factor: 4.429

Review 9.  Prostate specific antigen for screening for prostate cancer: an appraisal of Thai reports.

Authors:  Viroj Wiwanitkit
Journal:  Asian Pac J Cancer Prev       Date:  2004 Oct-Dec

10.  Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.

Authors:  B G Blijenberg; H Lilja; H Neels; U H Stenman
Journal:  BJU Int       Date:  2003-12       Impact factor: 5.588

View more
  1 in total

Review 1.  Falsely Undetectable Prostate-Specific Antigen (PSA) Due to Presence of an Inhibitory Serum Factor: A Case Report and Review of Pertinent Literature.

Authors:  Nicholas B Loudas; Anthony A Killeen; Vikram Palamalai; Christopher J Weight; Arpit Rao; L Chinsoo Cho
Journal:  Am J Case Rep       Date:  2019-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.